Global Antacids Market Size, Trends, and Growth Opportunity, By Type (Sodium Antacids, Calcium Antacids, Magnesium Antacids, Aluminium Antacids, Others), By Indication (Gastroesophageal Reflux Disease, Heartburn, Indigestion, Others), By Dosage Form (Tablets, Liquid, Others), By Route of Administration (Oral, Others),  By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-Users (Hospitals, Homecare, Speciality Centres, Others),  By Region (North America, Europe, Asia Pacific, Latin America, Middle East) and Forecast till 2030.
Global Antacids Market 
The Global Antacids Market was valued at USD 6.98 billion in 2022 and is expected to expand to USD 9.85 billion in 2030 at a CAGR of 4.39% during the forecast period 2023-2030.
Antacids are medicines that help in the neutralization of gastric acid present in the stomach. They are alkaline in nature and contain sodium, aluminum, magnesium, and calcium and mitigate pain, inflammation, and gastric acidity.
 Market Drivers
The changing dietary habits and the increased incidences of GERD and heartburn propel the growth of the market.
The increasing awareness about GERD and the growing geriatric population act as major factors for the growing market during the forecast period.
Market Restraints
Antacids associated with aluminum hydroxide involve side-Effects like milk-alkali syndrome, constipation, hypophosphatemia, aluminum poisoning, and osteomalacia which hinder the growth of the market.
Furthermore, the high cost of treatment restrains the growth of the global Antacids market.
COVID-19 Impact on Antacids Market 
The outbreak of covid-19 positively impacted the market as antacids are used in treating symptoms of acid reflux and heartburn in covid-19 patients which reduces the risk of mortality. 
Famotidine is mostly used antacid during a pandemic to reduce hyperacidity.
Impact of Russia Ukraine War on the Market
The conflict between Russia and Ukraine can have both direct and indirect impacts on the antacids market:
Disruptions in the supply chain: Many antacids manufacturers source components from Russia and Ukraine. The war may cause supply chain disruptions and delays, affecting antacids production and delivery.
Economic sanctions: Economic sanctions imposed on Russia may have an impact on the overall economy, as well as the demand for antacids in the region.
Market Segmentation 
The Global Antacids Market is segmented on the basis of Type, Indication, Dosage Form, Route of Administration, Distribution Channel, End-User, and Region. Based on Type, it is segmented into Sodium Antacids, Calcium Antacids, Magnesium Antacids, Aluminium Antacids, and Others. On the basis of Indication, it is segmented into Gastroesophageal Reflux Disease, Heartburn, Indigestion, and Others. Based on the Dosage Form, it is segmented into Tablets, liquids, and Others. On the basis of the Route of Administration, it is segmented into Oral and Other. Based on the Distribution Channel, it is segmented into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. Based on End-Users, it is segmented into Hospitals, Homecare, Speciality Centres, and Others. On the basis of Region, it is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 
Regional Analysis  
North America is likely to dominate the market over the forecast period owing to the increasing geriatric population and increased novel development in this region.
Asia Pacific is also anticipated to witness substantial growth because of the rising government support and initiatives to spread awareness in this region.
Key Players 
Various key players are listed in this report such as Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan NV, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd, Bristol Myers Squibb Company, GSK Plc, Bayer AG, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Procter & Gamble, Reckitt Benckiser Group PLC.
Market Taxonomy
By Type
• Sodium Antacids
• Calcium Antacids
• Magnesium Antacids
•  Aluminium Antacids
• Others 
By Indication
• Gastroesophageal Reflux Disease
• Heartburn
• Indigestion
• Others 
By Dosage Form
• Tablets
• Liquid
• Others
By Route of Administration 
• Oral 
• Others 
By Distribution Channel 
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By End-Users
• Hospitals
• Homecare
• Specialty Centres
• Others 
By Region 
• North America
• Europe
• Asia Pacific   
• Latin America
• Middle East and Africa
   Key Question Addressed by the Report
• What are the Key Opportunities in Global Antacids Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the role of key players in the value chain?
           

Global Antacids Market 
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Antacids Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Antacids Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Antacids Market Share Analysis, By Type
5.3 Antacids Market Size and Forecast, By Type
5.3.1 Sodium Antacids
5.3.2 Calcium Antacids
5.3.3 Magnesium Antacids
5.3.4 Aluminium Antacids
5.3.5 Others
6 Antacids Market, By Indication
6.1 Y-o-Y Growth Comparison, By Indication
6.2 Antacids Market Share Analysis, By Indication
6.3 Antacids Market Size and Forecast, By Indication
6.3.1 Gastroesophageal Reflux Disease
6.3.2 Heartburn
6.3.3 Indigestion
6.3.4 Others
7 Antacids Market, By Dosage Form 
7.1 Y-o-Y Growth Comparison, By Dosage Form 
7.2 Antacids Market Share Analysis, By Dosage Form 
7.3 Antacids Market Size and Forecast, By Dosage Form 
7.3.1 Tablets
7.3.2 Liquid
7.3.3 Others 
8 Antacids Market, By Route of Administration
8.1 Y-o-Y Growth Comparison, By Route of Administration
8.2 Antacids Market Share Analysis, By Route of Administration
8.3 Antacids Market Size and Forecast, By Route of Administration
8.3.1 Oral
8.3.2 Others
9 Antacids Market, By Distribution Channel 
9.1 Y-o-Y Growth Comparison, By Distribution Channel 
9.2 Antacids Market Share Analysis, By Distribution Channel 
9.3 Antacids Market Size and Forecast, By Distribution Channel 
9.3.1 Hospital Pharmacy
9.3.2 Online Pharmacy
9.3.3 Retail Pharmacy
10 Antacids Market, By End-Users 
10.1 Y-o-Y Growth Comparison, By End-Users 
10.2 Antacids Market Share Analysis, By End-Users 
10.3 Antacids Market Size and Forecast, By End-Users 
10.3.1 Hospitals
10.3.2 Homecare
10.3.3 Speciality Centres
10.3.4 Others 
11 Antacids Market, By Region
11.1 Antacids Market Share Analysis, By Region
11.2 Antacids Market Share Analysis, By Region
11.3 Antacids Market Size and Forecast, By Region
12 North America Antacids Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 North America Antacids Market Share Analysis, By Type
12.3 North America Antacids Market Size and Forecast, By Indication
12.4 North America Antacids Market Size and Forecast, By Dosage Form 
12.5 North America Antacids Market Size and Forecast, By Route of Administration
12.6 North America Antacids Market Size and Forecast, By Distribution Channel 
12.7 North America Antacids Market Size and Forecast, By End-Users 
12.8 North America Antacids Market Size and Forecast, By Country
12.8.1 U.S.
12.8.2 Canada
12.8.3 Mexico
13 Europe Antacids Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Europe Antacids Market Share Analysis, By Type
13.3 Europe Antacids Market Size and Forecast, By Indication
13.4 Europe Antacids Market Size and Forecast, By Dosage Form 
13.5 Europe Antacids Market Size and Forecast, By Route of Administration
13.6 Europe Antacids Market Size and Forecast, By Distribution Channel 
13.7 Europe Antacids Market Size and Forecast, By End-Users 
13.8 Europe Antacids Market Size and Forecast, By Country
13.8.1 Germany
13.8.2 France
13.8.3 Austria
13.8.4. Rest of Europe
14 Asia Pacific Antacids Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Asia Pacific Antacids Market Share Analysis, By Type
14.3 Asia Pacific Antacids Market Size and Forecast, By Indication
14.4 Asia Pacific Antacids Market Size and Forecast, By Dosage Form 
14.5 Asia Pacific Antacids Market Size and Forecast, By Route of Administration
14.6 Asia Pacific Antacids Market Size and Forecast, By Distribution Channel 
14.7 Asia Pacific Antacids Market Size and Forecast, By End-Users 
14.8 Asia Pacific Antacids Market Size and Forecast, By Country
14.8.1 China 
14.8.2 Japan
14.8.3 India
14.8.4. Rest of Asia Pacific
15 Latin America Antacids Market Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Latin America Antacids Market Share Analysis, By Type
15.3 Latin America Antacids Market Size and Forecast, By Indication
15.4 Latin America Antacids Market Size and Forecast, By Dosage Form 
15.5 Latin America Antacids Market Size and Forecast, By Route of Administration
15.6 Latin America Antacids Market Size and Forecast, By Distribution Channel 
15.7 Latin America Antacids Market Size and Forecast, By End-Users 
15.8 Latin America Antacids Market Size and Forecast, By Country
15.8.1. Brazil
15.8.2. Rest of Latin America
16 Middle East Antacids Market Analysis and Forecast (2023-2030)
16.1 Introduction
16.2 Middle East Antacids Market Share Analysis, By Type
16.3 Middle East Antacids Market Size and Forecast, By Indication
16.4 Middle East Antacids Market Size and Forecast, By Dosage Form 
16.5 Middle East Antacids Market Size and Forecast, By Route of Administration
16.6 Middle East Antacids Market Size and Forecast, By Distribution Channel 
16.7 Middle East Antacids Market Size and Forecast, By End-Users 
16.8 Middle East Antacids Market Size and Forecast, By Country
16.8.1. Saudi Arabia
16.8.2. UAE
16.8.3. Egypt
16.8.4. Kuwait
16.8.5. South Africa
17 Competitive Analysis
17.1 Competition Dashboard
17.2 Market share Analysis of Top Vendors
17.3 Key Development Strategies
18 Company Profiles
18.1 Pfizer Inc 
18.1.1 Overview
18.1.2 Offerings
18.1.3 Key Financials
18.1.4 Business Segment & Geographic Overview
18.1.5 Key Market Developments
18.1.6 Key Strategies
18.2 F. Hoffmann-La Roche Ltd 
18.2.1 Overview
18.2.2 Offerings
18.2.3 Key Financials
18.2.4 Business Segment & Geographic Overview
18.2.5 Key Market Developments
18.2.6 Key Strategies
18.3 Mylan NV 
18.3.1 Overview
18.3.2 Offerings
18.3.3 Key Financials
18.3.4 Business Segment & Geographic Overview
18.3.5 Key Market Developments
18.3.6 Key Strategies
18.4 Fresenius Kabi AG 
18.4.1 Overview
18.4.2 Offerings
18.4.3 Key Financials
18.4.4 Business Segment & Geographic Overview
18.4.5 Key Market Developments
18.4.6 Key Strategies
18.5 Hikma Pharmaceuticals PLC
18.5.1 Overview
18.5.2 Offerings
18.5.3 Key Financials
18.5.4 Business Segment & Geographic Overview
18.5.5 Key Market Developments
18.5.6 Key Strategies
18.6 Novartis AG 
18.6.1 Overview
18.6.2 Offerings
18.6.3 Key Financials
18.6.4 Business Segment & Geographic Overview
18.6.5 Key Market Developments
18.6.6 Key Strategies
18.7 Teva Pharmaceutical Industries Ltd 
18.7.1 Overview
18.7.2 Offerings
18.7.3 Key Financials
18.7.4 Business Segment & Geographic Overview
18.7.5 Key Market Developments
18.7.6 Key Strategies 
18.8 Bristol Myers Squibb Company
18.8.1 Overview
18.8.2 Offerings
18.8.3 Key Financials
18.8.4 Business Segment & Geographic Overview
18.8.5 Key Market Developments
18.8.6 Key Strategies
18.9 GSK Plc 
18.9.1 Overview
18.9.2 Offerings
18.9.3 Key Financials
18.9.4 Business Segment & Geographic Overview
18.9.5 Key Market Developments
18.9.6 Key Strategies
18.10 Bayer AG 
18.10.1 Overview
18.10.2 Offerings
18.10.3 Key Financials
18.10.4 Business Segment & Geographic Overview
18.10.5 Key Market Developments
18.10.6 Key Strategies
18.11 Sun Pharmaceutical Industries Ltd
18.11.1 Overview
18.11.2 Offerings
18.11.3 Key Financials
18.11.4 Business Segment & Geographic Overview
18.11.5 Key Market Developments
18.11.6 Key Strategies
18.12 Aurobindo Pharma 
18.12.1 Overview
18.12.2 Offerings
18.12.3 Key Financials
18.12.4 Business Segment & Geographic Overview
18.12.5 Key Market Developments
18.12.6 Key Strategies 
18.13 Procter & Gamble 
18.13.1 Overview
18.13.2 Offerings
18.13.3 Key Financials
18.13.4 Business Segment & Geographic Overview
18.13.5 Key Market Developments
18.13.6 Key Strategies
18.14 Reckitt Benckiser Group PLC 
18.14.1 Overview
18.14.2 Offerings
18.14.3 Key Financials
18.14.4 Business Segment & Geographic Overview
18.14.5 Key Market Developments
18.14.6 Key Strategies